BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8652825)

  • 1. Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events.
    Yamauchi A; Taga K; Mostowski HS; Bloom ET
    Blood; 1996 Jun; 87(12):5127-35. PubMed ID: 8652825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
    Roger R; Issaad C; Pallardy M; Léglise MC; Turhan AG; Bertoglio J; Bréard J
    Blood; 1996 Feb; 87(3):1113-22. PubMed ID: 8562937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-induced death by apoptosis in human lymphokine-activated natural killer cells.
    Taga K; Yamauchi A; Kabashima K; Bloom ET; Muller J; Tosato G
    Blood; 1996 Mar; 87(6):2411-8. PubMed ID: 8630405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cells.
    Frederick MJ; Yu TK; Krohn EG; Johnston DA; Grimm EA
    Immunopharmacology; 1996 Nov; 35(2):83-102. PubMed ID: 8956972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.
    Komatsu F; Kajiwara M
    Oncol Res; 2000; 12(1):17-24. PubMed ID: 11061342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-sensitive events in Fas-induced apoptosis in human NK cells include ceramide generation and protein tyrosine dephosphorylation.
    Furuke K; Bloom ET
    Int Immunol; 1998 Sep; 10(9):1261-72. PubMed ID: 9786425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines.
    Wu J; Suzuki H; Zhou YW; Liu W; Yoshihara M; Kato M; Akhand AA; Hayakawa A; Takeuchi K; Hossain K; Kurosawa M; Nakashima I
    J Cell Biochem; 2001; 82(2):200-14. PubMed ID: 11527146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity.
    Medvedev AE; Johnsen AC; Haux J; Steinkjer B; Egeberg K; Lynch DH; Sundan A; Espevik T
    Cytokine; 1997 Jun; 9(6):394-404. PubMed ID: 9199873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells.
    Umehara H; Takashima A; Minami Y; Bloom ET
    Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma.
    Tong AW; Lee JC; Wang RM; Ordonez G; Stone MJ
    Cancer Res; 1989 Aug; 49(15):4103-8. PubMed ID: 2545333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
    Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
    Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
    J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets.
    Blanchard DK; Hall RE; Djeu JY
    Int J Cancer; 1990 Feb; 45(2):312-9. PubMed ID: 1968054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin-2-activated T cells.
    Zhou YW; Komada Y; Inaba H; Deguchi T; Sugiyama K; Azuma E; Sakurai M
    Immunol Invest; 1998; 27(4-5):309-22. PubMed ID: 9730091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia.
    Verfaillie C; Kay N; Miller W; McGlave P
    Blood; 1990 Jul; 76(2):401-8. PubMed ID: 1695114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.
    Timonen T; Gahmberg CG; Patarroyo M
    Int J Cancer; 1990 Dec; 46(6):1035-40. PubMed ID: 1979068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
    Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
    J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.